May 2026 - TinyGems

WednesdayMay 27, 2026 10:00 am

Enterprise AI Users Decry Spiraling Costs of Coding Tools

Microsoft and Uber have put a face on a problem spreading through corporate America: AI tools that work but cost much more than anyone planned. The former began phasing out its Claude Code subscriptions in mid-May, with the bulk expiring at the end of June. Uber CTO Praveen Neppalli Naga confirmed the ride-share company had burned through its entire 2026 AI budget by April, just months after Uber rolled out Claude Code to approximately 5,000 engineers. Claude Code and similar tools charge per token used, rather than a flat monthly rate, so bills scale with every task. Costs per engineer…

TuesdayMay 26, 2026 10:00 am

Study Finds Many Young Adults Suffer Sexual Problems After Cancer Treatment

A new doctoral study from Sweden's Karolinska Institutet has found that sexual difficulties are common among young people who have survived cancer treatment. The nature and severity of those difficulties shift considerably based on cancer type and how intensively the patient was treated. Charlotta Bergström, a nurse and doctoral student at the Karolinska Institutet, led the research, which covered more than 1,000 patients. The study drew on Fex-Can, a research project tracking sexual and reproductive outcomes in cancer patients, with follow-up surveys over five years. Those findings were set against responses from a cancer-free peer group to establish a point…

FridayMay 22, 2026 10:30 am

Frontieras North America Inc. Targets Trillion-Dollar Energy, Chemicals Markets with Transformative Processing Technology

The company’s FASForm(TM) technology produces materials already used across multiple existing segments. What differentiates Frontieras within these sectors is the breadth of outputs generated from a single feedstock. Frontieras broke ground last month on its first commercial-scale project, which is designed to process approximately 7,500 tons of coal per day. For decades, coal's critics and coal's defenders have been arguing about the same thing: whether to burn it. Frontieras North America Inc. has a different question entirely. What happens when the industry stops burning coal and starts fractionating it? The answer, according to the company's FASForm(TM) technology, is six commercial…

WednesdayMay 20, 2026 10:00 am

Researchers Create Less Toxic, More Effective Immunotherapy Against Blood Cancer

University of North Carolina scientists have engineered immune cells that can destroy acute myeloid leukemia while sparing healthy blood tissue, overcoming a limitation that has plagued standard treatments, which have struggled to separate cancerous cells from normal cells. Immunologist Gianpietro Dotti and hematologist Paul Armistead directed research teams whose work appears in the journal Blood, offering an approach that may expand options for patients battling this deadly disease. Acute myeloid leukemia afflicts adults and children alike, with diagnoses rising steadily, particularly across America and countries experiencing population aging. The malignancy typically advances rapidly through the bone marrow and bloodstream once it develops. Unfortunately, existing therapies damage normal blood-forming…

MondayMay 18, 2026 10:00 am

Why China Is Unlikely to Use More Coal Even as Iran War Rages

Fighting in Iran has sent oil above $100 a barrel, roughly doubled LNG prices across Asia, and pushed coal higher too. When oil and gas grow costly, coal starts to look like the cheaper alternative, and the conventional wisdom holds that consumption will follow. In China, however, the way its coal market is structured means that outcome is far less certain than it looks. Coal generates around 60% of China’s electricity and accounts for over 95% of all carbon emissions produced by the power sector. Steel production, which produces 15–17% of national emissions, also depends heavily on coal. Despite the country’s continued reliance on coal-fired energy, current conditions in…

FridayMay 15, 2026 10:30 am

Frontieras North America Inc.’s Game-Changing Tech ‘Unlocks’ Coal as Multi-Output Industrial Feedstock

The company’s proprietary FASForm(TM) platform advancing new approach to coal. Frontieras processes coal into multiple commercially valuable outputs, tied to markets estimated at more than $2 trillion. Core thesis is that coal’s largest missed opportunity lies not in power generation alone but in its unrealized value as a diversified industrial resource. Global demand for energy is accelerating at a historic pace as artificial intelligence (“AI”), advanced manufacturing and industrial expansion place increasing pressure on existing power systems. Governments and industries are exploring nearly every available energy source to meet that demand, yet one of the world’s most abundant and energy-dense…

WednesdayMay 13, 2026 10:00 am

Pentagon Seeks to Mitigate Quantum Computing Risks to the F-35

The Pentagon is taking steps toshield the F-35's encryption systems from the growing threat posed by quantum computing. A contract notice published May 6, 2026, by the F-35 Joint Program Office signals the shift to quantum computing-proof encryption. The military is moving to future-proof one of the jet's core security systems before quantum computing advances enough to break current encryption. Known as the In-Line File Encryption Device, the component at the center of this work is a specialized security chip embedded in the aircraft. Its job is to check that every piece of software on the jet is genuine and…

MondayMay 11, 2026 9:05 am

Study Suggests Timing of Immunotherapy Could Impact Clinical Outcomes

A systematic review in JAMA Network Open suggests earlier administration of immune checkpoint inhibitor therapies may improve survival outcomes in patients being treated for late-stage solid tumors. The analysis pooled data from 29 studies encompassing more than 6,000 patients. Earlier timing was linked to gains in both survival endpoints, though prospective validation is required before scheduling adjustments can be broadly adopted. The studies covered tumor types like melanoma, gastric, renal cell, esophageal, small cell lung, urothelial, biliary tract, and hepatocellular carcinoma. Twenty-seven of the 29 were retrospective cohorts. The other two comprised a randomized trial in non-small cell lung cancer and a prospective cohort study in head and neck squamous cell carcinoma. The breadth of coverage reflects growing interest in whether treatment timing, not…

ThursdayMay 07, 2026 9:00 am

Frontieras North America’s Transformative Technology Reimagines Coal for the Future

Coal remains the largest source of electricity generation in the world. At the heart of Frontieras’s FASForm technology is a continuous solid carbon fractionation process that thermally cracks coal in a reducing atmosphere. Beyond fuels and hydrogen, the FASForm process enables the creation of additional valuable industrial chemicals and materials. Global energy systems are under increasing strain as industrial demand accelerates and reliable baseload power becomes more critical to economic stability. Frontieras North America is developing a breakthrough energy-processing technology known as FASForm(TM) that deconstructs coal and other solid hydrocarbons into multiple high-value fuels and industrial products, redefining the utility and economics of coal…

WednesdayMay 06, 2026 10:00 am

Blocking Fructose Metabolism Boosts Immune Response to Childhood Cancer

Researchers at Johns Hopkins may have found a new approach to group 3 medulloblastoma, a deadly and hard-to-treat pediatric brain cancer. Mouse experiments suggest that disrupting how tumor cells generate energy can slow the disease. The research was conducted at the Kimmel Cancer Center and published in Acta Neuropathologica Communications. Group 3 medulloblastoma is one of the most difficult pediatric brain cancers to treat, and effective therapies remain scarce. The new research reveals how tumor cells rewire their energy production to fuel rapid growth. It also shows that interfering with those processes can slow the disease. Senior author Ranjan Perera, Ph.D., of Johns Hopkins All Children's Hospital, said the work points toward a largely unexplored therapeutic avenue. According…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Month: May 2026